Telesis Bio, Inc.
MESSENGER RNA VACCINES AND USES THEREOF
Last updated:
Abstract:
The present invention provides, among other things, methods and compositions of formulating nucleic acid-containing nanoparticles for efficient delivery of payload in vivo such that the method and compositions can be used to generate mRNA vaccines.
Status:
Application
Type:
Utility
Filling date:
29 May 2019
Issue date:
16 Jan 2020